Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies

BACKGROUND: Monthly headache frequency directly correlates with personal/societal burden and impacts severity and preventive treatment decisions. This post hoc analysis identified shifts from higher to lower frequency headache categories over 6 months in patients with migraine participating in the P...

Descripción completa

Detalles Bibliográficos
Autores principales: Pozo-Rosich, Patricia, Dodick, David W., Ettrup, Anders, Hirman, Joe, Cady, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594902/
https://www.ncbi.nlm.nih.gov/pubmed/36284281
http://dx.doi.org/10.1186/s12883-022-02914-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594902/
https://www.ncbi.nlm.nih.gov/pubmed/36284281
http://dx.doi.org/10.1186/s12883-022-02914-9

Ejemplares similares